Lymphoma
Lymphoma is a malignant tumor originating from lymph nodes or lymphatic tissues. The main clinical manifestation is painless, progressive lymphadenopathy. The disease can occur at any age, but the peak age of onset is between 31 and 40 years old, with the peak of non-Hodgkin's lymphoma slightly earlier. The male-to-female ratio is 2-3:1.
-
Site of disease:
lymph -
Infectious :
Not contagious -
Frequent population:
Young Adults -
Related symptoms:
Lymph node enlargement hepatosplenomegaly weight loss night sweats persistent fever
Related Drugs
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
Sinopharm A-Think Pharmaceutical Co., Ltd.
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
Han Hui Pharmaceuticals Company Limited
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
Harbin Laiboten Pharmaceutical Co., Ltd.
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
Harbin Laiboten Pharmaceutical Co., Ltd.
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
RenHe Hetero Pharmaceuticals Ltd.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Bei Jing Scrianen Pharmaceutical Co., Ltd.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.